Teva to pay $250 million to end hepatitis C cases
One pharmaceutical company recently learned that it shouldnt exactly embrace the Earth-friendly mantra reduce, reuse, recycle.
February 21, 2012 at 05:51 AM
3 minute read
The original version of this story was published on Law.com
One pharmaceutical company recently learned that it shouldn't exactly embrace the Earth-friendly mantra “reduce, reuse, recycle.”
Last week Teva Pharmaceutical Industries Ltd. agreed to pay more than $250 million to settle more than 80 lawsuits in which colonoscopy patients from Las Vegas claim the company's anesthetic Propofol caused them to develop the liver disease hepatitis C. The plaintiffs claimed the Israel-based drug company intentionally sold the drug in oversize vials that doctors used for multiple patients, thus increasing the risk of spreading the incurable blood-borne disease.
Nevada health officials and the Centers for Disease Control and Prevention blamed a 2008 hepatitis C outbreak on the reuse of Propofol vials. Two years later, a state grand jury indicted a local doctor who ran the endoscopy clinic linked to many of the hepatitis cases.
According to Bloomberg, the $250 million deal resolves most of the remaining Propofol cases on the docket in state court in Las Vegas, as well as several multimillion-dollar verdicts against Teva, including a May 2010 case in which a jury awarded $500 million to a Las Vegas school principal who claims he developed hepatitis C after receiving tainted Propofol during a colonoscopy.
One pharmaceutical company recently learned that it shouldn't exactly embrace the Earth-friendly mantra “reduce, reuse, recycle.”
Last week
Nevada health officials and the Centers for Disease Control and Prevention blamed a 2008 hepatitis C outbreak on the reuse of Propofol vials. Two years later, a state grand jury indicted a local doctor who ran the endoscopy clinic linked to many of the hepatitis cases.
According to Bloomberg, the $250 million deal resolves most of the remaining Propofol cases on the docket in state court in Las Vegas, as well as several multimillion-dollar verdicts against Teva, including a May 2010 case in which a jury awarded $500 million to a Las Vegas school principal who claims he developed hepatitis C after receiving tainted Propofol during a colonoscopy.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Coinbase Hit With Antitrust Suit That Seeks to Change How Crypto Exchanges Operate
3 minute read
Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme
Trending Stories
- 1'Pull Back the Curtain': Ex-NFL Players Seek Discovery in Lawsuit Over League's Disability Plan
- 2Tensions Run High at Final Hearing Before Manhattan Congestion Pricing Takes Effect
- 3Improper Removal to Fed. Court Leads to $100K Bill for Blue Cross Blue Shield
- 4Michael Halpern, Beloved Key West Attorney, Dies at 72
- 5Burr & Forman, Smith Gambrell & Russell Promote More to Partner This Year
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
